CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

    
  FY 2020 FY 2021 FY 2022 FY 2023 FY 2024(Est.)
Net Sales 10,830 11,698 12,326 12,585 13,032

Cost of Sales
(% of Net Sales)

5,752
53.1%
6,438
55.0%
6,931
56.2%
7,107
56.5%
7,179
55.1%

Gross Profit
(% of Net Sales)

5,077
46.9%
5,260
45.0%
5,395
43.8%
5,478
43.5%
5,853
44.9%

SG&A expenses
(% of Net Sales)

4,092
37.8%
4,393
37.6%
4,654
37.8%
4,675
37.1%
4,985
38.3%

Operating Income 
(% of Net Sales)

984
9.1%
866
7.4%
741
6.0%
803
6.4%
868
6.7%

Ordinary Income 
(% of Net Sales)

952
8.8%
1,009
8.6%
834
6.8%
872
6.9%
900
6.9%

Net Income
(% of Net Sales)

659
6.1%
660
5.6%
482
3.9%
154
1.2%
967
7.4%

Net Sales by Sales Format(cons.)

Unit:million yen

 
  FY 2020 FY 2021 FY 2022 FY 2023 FY 2024(Est.)

Own-brand
(%)

6,640
61.3%
6,884
58.8%
6,986
56.7%
6,920
55.0%
7,300
56.0%
Overseas
(%)
2,943
27.2%
3,493
29.9%
4,000
32.5%
4,257
33.8%
4,428
34.0%
OEM Sales
(%)
1,245
11.5%
1,320
11.3%
1,340
10.9%
1,407
11.2%
1,304
10.0%
Total
(%)
10,830
100.0%
11,698
100.0%
12,326
100.0%
12,585
100.0%
13,032
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2020 FY 2021 FY 2022 FY 2023 FY 2024(Est.)

Current Assets

10,722 11,575 12,128 12,722 13,948

Fixed Assets

6,374 6,500 6,736 6,535 5,527

Total Assets
(Gross Assets)

17,097 18,075 18,865 19,258 19,474

Current Liabilities

2,583 2,573 2,816 2,967 2,856

Fixed Liabilities

1,286 1,282 1,325 1,347 1,325

Total Liabilities

3,869 3,855 4,141 4,314 4,181

Shareholders' Equity

13,227 14,220 14,723 14,944 15,294

Equity Ratio

77.4% 78.7% 78.0% 77.6% 78.5%

Cash Flow Data

Unit:million yen

  FY 2020 FY 2021 FY 2022 Fy 2023 FY 2024
(Est.)

Net cash provided by (used in) operating activities

1,249 1,248 478 698 1,936

Net cash provided by (used in) investing activities

△ 704 △ 585 43 △ 363 577

Net cash provided by (used in) financing activities

△ 845 △ 442 △ 356 △ 362 △ 336

Net increase in cash and cash equivalents

△ 343 330 288 68 2,177

Cash and cash equivalents at end of year

3,083 3,413 3,702 3,770 5,251

Free Cash Flow

544 663 522 335 2,513
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2020 FY 2021 FY 2022 FY 2023 FY 2024(Est.)
ROE 5.0% 4.8% 3.3% 1.0% 6.3%
EPS(yen) 71.19 72.61 53.00 16.92 106.22
BPS(yen) 1,454.41 1,563.55 1,618.10 1,641.59 1,679.99

Dividend per Share (yen)

37 37 37 37 39

Dividend Payout Ratio(cons.)

52.0% 51.0% 69.8% 218.7% 36.7%

TOP